Céline Jacquemont - Concepedia

Author

Céline Jacquemont

Fred Hutch Cancer Center

Also Known As

C Jacquemont, C. Jacquemont, Celine Jacquemont, Céline Jacquemont, Céline F. Jacquemont, Céline Jacquemont

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center University of Washington The University of Texas MD Anderson Cancer Center Mayo Clinic Hackensack University Medical Center

About

Céline Jacquemont is an author at Fred Hutch Cancer Center specializing in medicine, cell biology, and genome instability.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.6K
2	Cell Biology	6	6	411
3	Natural Sciences	3	3	291
4	Health Sciences	1	1	1.1K
5	Cellular Physiology	1	1	14

Céline Jacquemont

Publications

Citations

H-Index

Page 1

	Year	Citations
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers Wataru Sakai, Elizabeth M. Swisher, Beth Y. Karlan, Nature Cisplatin ResistanceSomatic VariantTumor HeterogeneitySecondary MutationsMedicine	2008	1.1K
Functional Restoration of BRCA2 Protein by Secondary <i>BRCA2</i> Mutations in <i>BRCA2</i> -Mutated Ovarian Carcinoma Wataru Sakai, Elizabeth M. Swisher, Céline Jacquemont, Cancer Research	2009	316
Proteasome Function Is Required for DNA Damage Response and Fanconi Anemia Pathway Activation Céline Jacquemont, Toshiyasu Taniguchi Cancer Research ChromatinGenome InstabilityProteasome InhibitorsDna Cross-linking AgentsProtein Function	2007	213
A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining Céline Baldeyron, Emilie Jacquemin, Julianne Smith, Oncogene Genome InstabilityGeneticsGenomic MechanismMolecular BiologyGenetic Mechanism	2002	97
FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2 María Castellà, Céline Jacquemont, Elizabeth L. Thompson, PLoS Genetics ChromatinGenome InstabilityTranscriptional RegulationFanconi AnemiaFanci Regulates Recruitment	2015	77
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin Céline Jacquemont, Julian A. Simon, Alan D. D’Andrea, Molecular Cancer	2012	62
DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA Processing Philamer Calses, Kiranjit K. Dhillon, Nyka Tucker, Cell Reports Dna DamageGeneticsMolecular BiologySerine 153Dgcr8 Mediates Repair	2017	51
Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non–small Cell Lung Cancer Brandon S. Sheffield, Regan Fulton, Steve E. Kalloger, Journal of Histochemistry & Cytochemistry	2016	32
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial Mark N. Stein, Ecaterina E. Dumbrava, Benjamin A. Teply, Nature Communications Cancer ManagementImmunologyPharmacotherapyPancreatic CancerOncology	2024	29
NEK8 regulates DNA damage-induced RAD51 foci formation and replication fork protection Antonio Abeyta, María Castellà, Céline Jacquemont, Cell Cycle ChromatinGenome InstabilityDna DamageCell RegulationChromatin Remodeling	2016	27

Page 1